|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 275, Issue 41, 32281-32288, October 13, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Expression of Antisense to Integrin Subunit
3
Inhibits Microvascular Endothelial Cell Capillary Tube Formation in
Fibrin*
§,
Department of Biochemistry and Molecular
Biology, Pennsylvania State University College of Medicine, Hershey,
Pennsylvania 17033 and the ¶ Department of Oral Molecular Biology,
School of Dentistry, Oregon Health Sciences University,
Portland, Oregon 97201
v
3
antagonists are potent angiogenesis inhibitors, and several different
classes of inhibitors have been developed, including monoclonal
antibodies, synthetic peptides, and small organic molecules. However,
each class of inhibitor works by the same principal, by blocking the
binding of ligands to v3. In an effort to
develop an v3 inhibitor that
down-regulates the actual level of v3, we
developed an antisense strategy to inhibit
v3 expression in vitro.
3 antisense expressed in endothelial cells specifically down-regulated v3 and inhibited capillary
tube formation, with the extent of down-regulation correlating with the
extent of tube formation inhibition. This inhibition was
matrix-specific, since tube formation was not inhibited in Matrigel.
These findings support the notion that v3
is required for an essential step of angiogenesis in fibrin, namely
capillary tube formation. These results suggest that pseudogenetic
inhibition of 3 integrins using antisense techniques may
ultimately provide a therapeutic means to inhibit angiogenesis in
vivo.
*
This work was supported by a Student Award from the American
Heart Association, Pennsylvania Affiliate (to S. M. D.), Grant-in-aid S98695P from the American Heart Association, Pennsylvania Affiliate (to
D. H. F.), and NHLBI, National Institutes of Health Grants R29HL53997
and K02HL04215 (to D. H. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
503-494-8602; Fax: 503-494-8918; E-mail:
farrelld@ohsu.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Matsumae, Y. Yoshida, K. Ono, K. Togi, K. Inoue, Y. Furukawa, Y. Nakashima, Y. Kojima, M. Nobuyoshi, T. Kita, et al. CCN1 Knockdown Suppresses Neointimal Hyperplasia in a Rat Artery Balloon Injury Model Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1077 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jendreyko, M. Popkov, R. R. Beerli, J. Chung, D. B. McGavern, C. Rader, and C. F. Barbas III Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell Surface Receptors J. Biol. Chem., November 28, 2003; 278(48): 47812 - 47819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sarno, H. Ha, N. Weinsetel, and M. E. Tolmasky Inhibition of Aminoglycoside 6'-N-Acetyltransferase Type Ib-Mediated Amikacin Resistance by Antisense Oligodeoxynucleotides Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3296 - 3304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Salcedo, X. Zhang, H. A. Young, N. Michael, K. Wasserman, W.-H. Ma, M. Martins-Green, W. J. Murphy, and J. J. Oppenheim Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells Blood, September 15, 2003; 102(6): 1966 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Leu, S. C.-T. Lam, and L. F. Lau Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins alpha vbeta 3 and alpha 6beta 1 in Human Umbilical Vein Endothelial Cells J. Biol. Chem., November 22, 2002; 277(48): 46248 - 46255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Castellon, S. Caballero, H. K. Hamdi, S. R. Atilano, A. M. Aoki, R. W. Tarnuzzer, M. C. Kenney, M. B. Grant, and A. V. Ljubimov Effects of Tenascin-C on Normal and Diabetic Retinal Endothelial Cells in Culture Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2758 - 2766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cieslak, J. Niewiarowska, M. Nawrot, M. Koziolkiewicz, W. J. Stec, and C. S. Cierniewski DNAzymes to beta 1 and beta 3 mRNA Down-regulate Expression of the Targeted Integrins and Inhibit Endothelial Cell Capillary Tube Formation in Fibrin and Matrigel J. Biol. Chem., February 22, 2002; 277(9): 6779 - 6787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mochizuki, T. Nakamura, H. Kanetake, and S. Kanda Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn J. Cell Sci., January 1, 2002; 115(1): 175 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins J. Cell Biol., October 29, 2001; 155(3): 459 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Rupp and C. D. Little Integrins in Vascular Development Circ. Res., September 28, 2001; 89(7): 566 - 572. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |